Stay updated on Miransertib in Overgrowth Spectrum Clinical Trial

Sign up to get notified when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Miransertib in Overgrowth Spectrum Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T15:59:45.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T09:36:06.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-30T04:38:35.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-23T01:53:57.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:07:46.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the removal of detailed study descriptions and eligibility criteria for a clinical trial involving miransertib, while adding new identifiers and collaborators.
    Difference
    36%
    Check dated 2025-04-23T23:11:16.000Z thumbnail image

Stay in the know with updates to Miransertib in Overgrowth Spectrum Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.